Evidence map›Paper›PMID 42436879›Full record

ArticleBlood neoplasia2026

Ten-day decitabine vs "3+7" in patients with AML aged ≥60 years: long-term results of the randomized phase 3 EORTC trial AML21.

Michael Lübbert, Pierre W Wijermans, Michal Kicinski, Sylvain Chantepie, Walter J F M Van der Velden, Richard Noppeney, Laimonas Griškevičius, Andreas Neubauer, Martina Crysandt, Radovan Vrhovac and 27 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood neoplasia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Michael LübbertDepartment of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany.
Pierre W WijermansHaga Ziekenhuis Hospital, The Hague, The Netherlands.
Michal KicinskiEuropean Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.
Sylvain ChantepieInstitut d'Hématologie de Basse Normandie, Centre Hospitalier Universitaire de Caen, Caen, France.
Walter J F M Van der VeldenDepartment of Hematology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Richard NoppeneyDepartment of Hematology, Krankenhaus der Barmherzigen Brüder Trier, Trier, Germany.
Laimonas GriškevičiusVilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania.
Andreas NeubauerDepartment of Internal Medicine, Hematology, Oncology and Immunology, Philipps University, Campus Marburg, Marburg, Germany.
Martina CrysandtDepartment of Hematology, Oncology, Hemostasiology and Stem Cell Transplantation, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany.
Radovan VrhovacDepartment of Haematology, University Hospital Centre Zagreb, Zagreb, Croatia.
Mario LuppiDivision of Hematology, Department of Medical and Surgical Sciences, Azienda Ospedaliera Universitaria of Udine, Italy.
Stephan FuhrmannOnkologie Berlin-Mitte, Berlin, Germany.
Ernesta AudisioDepartment of Hematology, Città della Salute e della Scienza di Torino, Torino, Italy.
Anna CandoniDivision of Hematology, Department of Medical and Surgical Sciences, Azienda Ospedaliera Universitaria of Udine, Italy.
Olivier LegrandService d'hématologie et de thérapie cellulaire, Hôpital Saint-Antoine, Université Pierre et Marie Curie, Paris, France.
Robin FoàDivision of Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Gianluca GaidanoDivision of Hematology, Department of Translational Medicine, University of Eastern Piedmont and Azienda Ospedaliero-Universitaria Maggiore della Carita,' Novara, Italy.
Danielle van Lammeren-VenemaHaga Ziekenhuis Hospital, The Hague, The Netherlands.
Eduardus F M PosthumaDepartment of Hematology, Reinier de Graaf Hospital, Delft, The Netherlands.
Mels HoogendoornFrisius MC, Leeuwarden, The Netherlands.
Anne GirautEuropean Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.
Stephanie AntunesEuropean Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.
Marian Stevens-KroefDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Joop H JansenHematology Laboratory, Department Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.
Aniek O de GraafHematology Laboratory, Department Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.
Fabio EfficaceItalian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy.
Emanuele AmmatunaUniversity Medical Center Groningen, Groningen, The Netherlands.
Quentin LevesqueInstitut d'Hématologie de Basse Normandie, Centre Hospitalier Universitaire de Caen, Caen, France.
Ralph WäschDepartment of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany.
Heiko BeckerDepartment of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany.
Nicole BlijlevensDepartment of Hematology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Ulrich DührsenDepartment of Hematology and Stem Cell Transplantation, University Hospital of Essen, Essen, Germany.
Frédéric BaronUniversity and Centre Hospitalier Universitaire of Liège, Liège, Belgium.
Stefan SuciuEuropean Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.
Adriano VendittiDivision of Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Gerwin HulsUniversity Medical Center Groningen, Groningen, The Netherlands.
EORTC Leukemia Group, Italian Group for Adult Hematologic Diseases, and German MDS Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42436879
PMCPMC13355440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.